Oric Pharmaceuticals, Inc. (ORIC)
↓ Download CSVKey ratios (FY2025)
-33.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$143.00M | -$142.90M | -$110.78M | -$91.77M | -$78.87M | -$74.19M | -$28.57M | -$22.37M | — |
| Net Income | -$129.47M | -$127.85M | -$100.70M | -$89.12M | -$78.72M | -$73.70M | -$26.88M | -$21.36M | — |
| EPS (Diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | — | — | — | — |
| Total Assets | $408.89M | $274.14M | $252.01M | $247.18M | $298.64M | $299.00M | $94.09M | — | — |
| Total Liabilities | $24.53M | $31.02M | $27.92M | $24.83M | $25.67M | $9.22M | $6.12M | — | — |
| Shareholders' Equity | $384.36M | $243.12M | $224.09M | $222.35M | $272.98M | $289.78M | -$90.08M | -$64.43M | -$43.61M |
| Cash & Equivalents | $45.67M | $59.41M | $23.38M | $66.84M | $226.01M | $78.45M | $89.16M | — | — |
| Operating Cash Flow | -$110.97M | -$112.66M | -$85.69M | -$75.14M | -$59.54M | -$45.27M | -$23.53M | -$20.68M | — |
| Capital Expenditures | $712.0K | $1.19M | $849.0K | $2.08M | $939.0K | $667.0K | $768.0K | $525.0K | — |
| Shares Outstanding | 98.53M | 71.02M | 54.87M | 45.09M | 39.43M | 36.67M | 1.98M | — | — |